O
Oxylabs
AI · Vilnius, Lithuania · Founded 2015
Proxy infrastructure and web data collection tools that help organizations gather and access public web data at scale MoreLess
Oxylabs is a company that specializes in web intelligence collection. The company provides a variety of services to its clients, including a large-scale proxy service and a web scraper API. These services are designed to help businesses gather data from the web at scale.
The company's proxy service includes a network of over 100 million residential proxies. This allows clients to access web content from a variety of locations around the world, without being blocked. The company's web scraper API is a tool that allows clients to extract data from websites in a structured format.
Oxylabs serves a global client base, including companies in the e-commerce, market research, and cybersecurity industries. The company's business model is based on a subscription-based service, with pricing determined by the amount of data that a client needs to gather.
Keywords: web intelligence, data collection, proxy service, residential proxies, web scraper API, data extraction, e-commerce, market research, cybersecurity, data gathering
Company overview
Oxylabs company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2015
- Headquarters
- Vilnius, Lithuania
- Employees
- 492
- Open positions
- 52
- Dealroom signal
- 89.9
- Investment activity
- 3 companies · latest Oct 2025
- Capital deployed
- $2K
- Preferred round
- ACQUISITION
Valuation & funding
Oxylabs funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VCOther financing | Jul 2026 | $130M | $3.6B | Warburg Pincus | ↗ |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $350M | +792.9% | 492 |
| 2025 | $39M | 0% | 360 |
| 2024 | $39M | 0% | 338 |
| 2023 | $39M | 0% | 338 |
| 2022 | $39M | 0% | 333 |
| 2021 | $39M | 0% | 259 |
| 2020 | $39M | — | 183 |
Growth signals
Oxylabs website traffic
Latest recorded traffic for Oxylabs is 530K monthly website visits, up 3.9% over the last three months. Oxylabs's team grew 36.7% over the past year.
Hiring
Open positions at Oxylabs
Current openings linked to this company in Dealroom.
Comparisons
Oxylabs compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Oxylabs investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
TD AutonomyVilnius, LithuaniaAutonomous targeting modules for battlefield drone manufacturers
$9Kvaluation
ScrapingBeeParis, FranceHandles headless browsers and rotates proxies for you so you can focus on data extraction
→
WebshareSan Francisco, United StatesBuy Proxy Servers | Fast & Affordable | Webshare
→
Talent graph
Oxylabs's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Oxylabs has talent and traffic
In the news
Latest news about Oxylabs
Recent press, funding announcements, and product moves mentioning Oxylabs — open to read from the original sources.
Market sentiment
What the market is saying about Oxylabs
An AI-synthesized read of the highest-engagement posts about Oxylabs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Oxylabs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








